<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Alterity Therapeutics Limited

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Alterity Therapeutics Limited

    We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases. Alterity Therapeutics was incorporated in Melbourne, Australia in 1997 as Prana Biotechnology and has offices in Melbourne, Australia, and San Francisco, USA. The Company listed on the Australian Securities Exchange in 2000 and listed on the NASDAQ in 2002. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Geoffrey Kempler
    • FOUNDED
      1997
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Idera Pharmaceuticals, Inc.

    Idera Pharmaceuticals, Inc.

    Idera Pharmaceuticals is a clinical-stage biopharmaceutical company developing nov...

    Idera Pharmaceuticals is a clinical-stage bioph...

    Filing Type:    PU
    Sientra, Inc.

    Sientra, Inc.

    Headquartered in Santa Barbara, California, Sientra is a diversified global medica...

    Headquartered in Santa Barbara, California, Sie...

    Filing Type:    PU
    Calithera Biosciences, Inc.

    Calithera Biosciences, Inc.

    Calithera is a clinical-stage biopharmaceutical company pioneering the discovery a...

    Calithera is a clinical-stage biopharmaceutical...

    Filing Type:    PU
    PDS Biotechnology Corporation

    PDS Biotechnology Corporation

    PDS Biotechnology has a growing pipeline of clinical-stage immunotherapies to trea...

    PDS Biotechnology has a growing pipeline of cli...

    Filing Type:    PU
    Novartis AG

    Novartis AG

    Novartis is reimagining medicine to improve and extend people’s lives. As a leadin...

    Novartis is reimagining medicine to improve and...

    Filing Type:    PU
    Innovate Biopharmaceuticals, Inc.

    Innovate Biopharmaceuticals, Inc.

    Innovate is a publicly traded (Nasdaq: INNT) clinical stage biotechnology company ...

    Innovate is a publicly traded (Nasdaq: INNT) cl...

    Filing Type:    PU
    Cortexyme, Inc.

    Cortexyme, Inc.

    Cortexyme is a biopharmaceutical company developing therapeutics based on data sup...

    Cortexyme is a biopharmaceutical company develo...

    Filing Type:    PU
    Brainstorm Cell Therapeutics Inc.

    Brainstorm Cell Therapeutics Inc.

    BrainStorm (NASDAQ:BCLI) is a biotechnology company developing innovative, autolog...

    BrainStorm (NASDAQ:BCLI) is a biotechnology com...

    Filing Type:    PU
    Karuna Therapeutics, Inc.

    Karuna Therapeutics, Inc.

    We are an innovative clinical-stage biopharmaceutical company primarily focused on...

    We are an innovative clinical-stage biopharmace...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.